Senti Biosciences issues senior secured convertible notes with 200% maturity payment.
Senti Holdings Inc. issued senior secured convertible notes requiring 200% repayment of principal at maturity. The offering provides capital financing with conversion rights, typical for biotech companies seeking non-dilutive funding.
View filing at SEC.gov →